Navigation Links
Tested a drug that strengthens the analgesic effect of opioids without increasing constipation
Date:3/31/2014

Scientists from the University of Granada have taken part, alongside the Esteve laboratory, in the development of a new drug that multiplies the analgesic effect of opioids (drugs for treating intense pain), without increasing constipation, one of the most common side-effects of these drugs, among which is morphine.

This important scientific breakthrough has been published in The Journal of Pharmacology and Experimental Therapeutics, and has been chosen as its outstanding article in the month of January. So far, the University of Granada researchers have published the results from testing this molecule on mice.

Opium derivates have been used since ancient times to treat pain. Currently, these and similar products (opioids) are the drugs used to treat various types of intense pain, such as post-operatory pain, cancer pain or internal-organ pain. The prolonged use of opioids causes strong constipation, which is a substantial drawback to their administration, since it substantially diminishes patient well-being.

The recently-published article proves that S1RA, a drug that blocks the sigma-1 receptor, manages to multiply solely the beneficial effect of the opioids; that is, their pain-killing properties.

The sigma-1 receptor is a very small protein that acts as a neuro-modulator, physically linking to other proteins (among which are the opioid receptors) and modifying their function.

As Enrique Cobos del Moral, one of the authors and a researcher at the University of Granada Institute of Neuroscience, explains, opioids are basically "centrally-acting" drugs; that is, they act directly upon the brain and the spinal medula. However, when opioids are associated with sigma-1 receptor blockers, their pain-killing effects are brought about by acting upon other areas; specifically, on the peripheral nervous system. From this, it is deduced that the sigma-1 receptor is a biological brake that prevents peripheral opioid analgesia, and that this brake can be eliminated by pharmacological treatment so as to increase the pain-killing power of opioids.

This scientific breakthrough is of huge importance for the well-being of patients suffering from pain, since, in the short term, it will allow the development of more efficient painkillers with fewer side-effects.

Esteve is working on the development of this medication, which is currently in Clinical Phase II


'/>"/>

Contact: Enrique J. Cobos del Moral
ejcobos@ugr.es
34-958-243-538
University of Granada
Source:Eurekalert  

Related medicine news :

1. Study questions anti-cancer mechanisms of drug tested in clinical trials
2. Data show drug being tested to reduce cardiovascular events increased risk of heart attack
3. Kirkman® Adds New Comprehensive Antioxidant to Ultra Tested® Product Line: Antioxidant/Cell Protect – Hypoallergenic
4. Brain Research Labs Brain Health And Performance News: Pioneer in the Field of Cognitive Performance and Health Succeeds with Clinically-Tested Natural Solutions
5. Fully Dissolvable, Temporary Stent for Opening Heart Artery Blockages Now Being Tested at The Mount Sinai Medical Center
6. Magellan Echo to Be Tested by Heart Rate Watch Company
7. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
8. This Tested and Proven Ingredient Should be in Every Adults Daily Regime for Younger Skin, Says Sublime Beauty
9. SafeToSleep Baby Monitor Wins Parent Tested Parent Approved (PTPA) Award
10. Through New Innovative Measures, Highly Pathogenic Microbes Will Now Be Tested Clinically, Strengthening The Front Line In The Fight Against Food-Borne Illness
11. Handheld device for detecting counterfeit and substandard medicines tested by PQM
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tested a drug that strengthens the analgesic effect of opioids without increasing constipation
(Date:10/15/2019)... ... October 15, 2019 , ... Labeling ... IFU Guidance , **An FDAnews Webinar**, Tuesday, October 29, 2019, 1:30-3:00 p.m. EDT, ... guidance have on new drug applications and biologics license applications? , How will ...
(Date:10/11/2019)... ... October 11, 2019 , ... Only 6% of orthopedic ... of them, as well as a female physician leading the sports medicine program. These ... girls who want to succeed in traditionally male-oriented fields. , Orthopedic medicine ...
(Date:10/10/2019)... ... October 10, 2019 , ... Santa Rosa Consulting, ... for the healthcare industry, has completed the first phase of a comprehensive strategic ... of The Bahamas towards a fully integrated health information management system (iHIMS). ...
(Date:10/8/2019)... ... October 08, 2019 , ... What unique insights can three ... of aging and wellness in the nation? That question will be answered at ICAA ... Leadership Summit and Expo. The event will take place October 10-12, 2019, at the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... for the Department of Veterans Affairs Community Care Referrals and Authorizations program. The ... the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by community ...
Breaking Medicine News(10 mins):
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted to ... in embittered divorce battles make better decisions and become truly child focused. This objective ... bully, be resilient, and STOP the cycle! Don’t be a divorce bully!” (published by ...
(Date:10/11/2019)... ... October 11, 2019 , ... American Case Management Association (ACMA) ... dedication, compassion and quality patient outcomes achieved by case management professionals across the ... link between patients, providers and payers to improve health outcomes across the care ...
(Date:10/10/2019)... ... October 10, 2019 , ... ... of research in the field of reproductive medicine, with six abstracts accepted for ... for reproductive experts, slated for October 12-16, 2019, in Philadelphia. , “Ovation will ...
Breaking Medicine Technology: